Treatment of neuropsychiatric disorders

Details Treatment of neuropsychiatric disorders Treatment of neuropsychiatric disorders

1990-02-23

1995-11-21

Stone, Jacqueline

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 12, 514 14, 514 16, 514806, 514879, A61K 3736

Patent

active

054687268

ABSTRACT:
The administration of Somatostatin and growth hormone releasing factor at useful dosage levels alleviates the symptoms of various neuropsychiatric disorders.
Growth hormone and neuropsychiatric responses to the administration of growth hormone releasing factor to mammals indicate its usefulness as an antemortem marker for senile dementia of the Alzheimer's type.

REFERENCES:
patent: 4622312 (1986-11-01), Felix et al.
patent: 4727041 (1988-02-01), Aroonsakul
patent: 4791099 (1988-12-01), Aroonsakul
patent: 4902680 (1990-02-01), Aroonsakul

Affiliated with

Also associated with

Rating

Treatment of neuropsychiatric disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of neuropsychiatric disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of neuropsychiatric disorders will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1137144